|MGD006 Interim data at ESMO, with abstracts off embargo at five past midnight 8/31. For as far along as this study seems to be, I note that the Netherlands sites are not yet recruiting. This apparently hasn't knocked them off their deadline (or has it?).|
One of the biotechs on summer sale, hitting multiyear lows on no obvious news. Anyone aside from me buying here (sold put position, getting substantial in size)?
Earnings this afternoon, clearly market doesn't expect anything good. 010 study completed. Added a Hep A vaccine cohort since the interim data was published last year, and there's been nothing said yet. Was expecting data from this cohort imminently.